Anxiogenic-like effects limit rewarding effects of cocaine in BALB/cByJ mice

被引:24
作者
David, V
Gold, LH
Koob, GF
Cazala, P
机构
[1] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA USA
[2] Univ Bordeaux 1, Cognit Neurosci Lab, CNRS UMR 5807, F-33405 Talence, France
关键词
intravenous and intracranial self-administration; reward; reinforcement; trait anxiety; stress; cocaine; mice;
D O I
10.1016/S0893-133X(00)00205-0
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Previous studies have reported intravenous cocaine self-administration behavior in several strains of mice with the exception of BALB/cByJ, a strain considered a mouse model of high emotional reactivity. The present experiments further investigated acquisition of self-administration in BALB/cByJ mice using a low dose and a habituation session. Following evidence of an initial drug-seeking behavior, we observed a progressive decline of intravenous self-administration. Pretreatment with diazepam (0.5 mg/kg, IF), reinstated cocaine-maintained responding. To test the hypothesis that injections directly into a reward-relevant brain region might support consistent cocaine-seeking behavior, BALB/cByJ mice implanted in the nucleus accumbens (NAc) or the caudate-putamen nucleus (CPu) were trained to discriminate between the arm enabling a microinjection of cocaine (30 pmol/50 nl or 150 pmol/50 nl) and the neutral arm of a Y-maze. Only NAc subjects exhibited a spatial discrimination toward the cocaine-reinforced arm and the D2 antagonist, sulpiride (50 mg/kg, IF) eliminated intra-NAc cocaine self-administration. However, after several days of cocaine self-injection, animals developed an approach/avoidance-like behavior between the start box and the reinforced arm. This behavior was suppressed by systemic diazepam (I mg/kg, IF) pretreatment. We conclude that: (1) medio-ventral NAc is involved both in the rewarding (via a D2 dopaminergic mechanism) and aversive effects of cocaine in mice; and (2) anxiolytic pretreatment (diazepam) indirectly enhanced the reinforcing properties of cocaine in BALB/cByJ, suggesting that emotionality carr act as a protective mechanism against stimulant abuse. (C) 2001 American College of Neuropsychopharmacology. Published by Elsevier Science Inc.
引用
收藏
页码:300 / 318
页数:19
相关论文
共 89 条
[1]
NEW PERSPECTIVES IN BASAL FOREBRAIN ORGANIZATION OF SPECIAL RELEVANCE FOR NEUROPSYCHIATRIC DISORDERS - THE STRIATOPALLIDAL, AMYGDALOID, AND CORTICOPETAL COMPONENTS OF SUBSTANTIA INNOMINATA [J].
ALHEID, GF ;
HEIMER, L .
NEUROSCIENCE, 1988, 27 (01) :1-39
[2]
EPIDEMIOLOGIC EVIDENCE ON COCAINE USE AND PANIC ATTACKS [J].
ANTHONY, JC ;
TIEN, AY ;
PETRONIS, KR .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 129 (03) :543-549
[3]
ARONSON TA, 1986, AM J PSYCHIAT, V143, P643
[4]
Neuropharmacological mechanisms of drug reward: Beyond dopamine in the nucleus accumbens [J].
Bardo, MT .
CRITICAL REVIEWS IN NEUROBIOLOGY, 1998, 12 (1-2) :37-67
[5]
Psychobiology of novelty seeking and drug seeking behavior [J].
Bardo, MT ;
Donohew, RL ;
Harrington, NG .
BEHAVIOURAL BRAIN RESEARCH, 1996, 77 (1-2) :23-43
[6]
Further pharmacological validation of the BALB/c neophobia in the free exploratory paradigm as an animal model of trait anxiety [J].
Belzung, C ;
Berton, F .
BEHAVIOURAL PHARMACOLOGY, 1997, 8 (6-7) :541-548
[7]
Effects of chronic alcohol consumption or Diazepam administration on item recognition and temporal ordering in a spatial working memory task in mice [J].
Borde, N ;
Jaffard, R ;
Béracochéa, D .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (07) :2380-2387
[8]
Neurochemical mediators of anxiety have inconsistent effects on hypothalamic self-stimulation in rats [J].
Borisenko, SA ;
Meng, QH ;
Rauhala, P ;
Mannisto, PT .
PHARMACOLOGY & TOXICOLOGY, 1996, 78 (05) :354-360
[9]
THE EFFECT OF DAU-6215, A NOVEL 5HT-3 ANTAGONIST, IN ANIMAL-MODELS OF ANXIETY [J].
BORSINI, F ;
BRAMBILLA, A ;
CESANA, R ;
DONETTI, A .
PHARMACOLOGICAL RESEARCH, 1993, 27 (02) :151-164
[10]
Method for training operant responding and evaluating cocaine self-administration behavior in mutant mice [J].
Caine, SB ;
Negus, SS ;
Mello, NK .
PSYCHOPHARMACOLOGY, 1999, 147 (01) :22-24